Skip to main content
Premium Trial:

Request an Annual Quote

Protein Discovery Uses $2.2M VC Cash to Fund New Mass-Spec Service

NEW YORK, Oct. 25 (GenomeWeb News) - Protein Discovery will use a $2.2 million Series B round of venture-capital financing to launch a new mass spectrometry tissue-imaging service, the company said today.

 

Protein Discovery, based in Knoxville, Tenn., relies on processes and technology licensed from VanderbiltUniversityand the Universityof Texas.

 

The financing round, which closed yesterday, was led by the Southern Appalachian Fund with help from MB Venture Partners, Nashville Capital Network, VanderbiltUniversity, and others, Protein Discovery said.

 

The investment will be supplemented by additional financial support from the Southern Appalachian Fund's Operational Assistance program, the firm said. Chuck Witkowski, president and CEO of Protein Discovery, said this additional cash together with revenue expected from the new service business "will provide operational cash flow and allow us to accelerate our product development efforts."

 

The company is developing a suite of sample-preparation products for mass spectrometry that is currently in beta testing, Witkowski told GenomeWeb News today.

The Scan

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.